RxDoctor Payments Data

Juan Serrato, MD

Orthopaedic Surgery · Edinburg, TXNPI 1659551216

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (55.7%), food and beverage and education — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Smith+Nephew at 35.9% of the total. Reporting peaked in 2019 at $8,092 and has fallen 54.0% since, to $3,719 in 2025.

$27,338in general payments, 2019–2025

Across 209 payments — averaging $130.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$10K
  • Stryker$3K
  • Medinc Of Texas$2K
  • Advanced Orthopaedic Solutions, Inc.$2K
  • Anika Therapeutics, Inc.$2K
  • Microport Orthopedics Inc$2K
  • plus $7K from 12 others
$52,124in research payments, 2019–2025

Across 17 payments — averaging $3066.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$46K
  • GE HealthCare$2K
  • Bayer$2K
  • Regeneron$2K

What the payments were for

  • Travel & lodging$15,23556%
  • Food & beverage$9,98137%
  • Education$2,1228%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,338 in reported general payments places this provider in the 80th percentile of 1,337 orthopaedic surgery providers in Texas.

See all orthopaedic surgery providers in Texas →

Medicare billing

Part B allowed, 2024
$51,818
Medicare patients
101
Services billed
2,064

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium222$2,645
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen110$882
Methylprednisolone64$501
Cyclobenzaprine Hcl62$240
Acetaminophen-CodeineAcetaminophen With Codeine28$227
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen24$174
Tramadol Hcl50$172

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Edinburg

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →